CL01
UPSFRe001-A
General
Cell Line |
|
hPSCreg name | UPSFRe001-A |
Cite as: | UPSFRe001-A (RRID:CVCL_C864) |
Alternative name(s) |
CL01
|
Cell line type | Human embryonic stem cell (hESC) |
Similar lines |
|
Last update | 28th July 2017 |
User feedback | |
Provider |
|
Generator |
Université Paris-Sud 11 (UPSFR)
Contact:
ESTeam Paris Sud |
Derivation country | France |
External Databases |
|
Cellosaurus | CVCL_C864 |
Wikidata | Q54813493 |
General Information |
|
Publications | |
* Is the cell line readily obtainable for third parties? |
Yes |
Donor Information
General Donor Information |
|
Sex | male |
Phenotype and Disease related information (Donor) |
|
Diseases | A disease was diagnosed.
|
Disease associated phenotypes |
|
Ethics
Alternatives to consent are available? | Yes |
Alternatives to consent | |
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? | Yes |
Name of accrediting authority involved? | Agence de la biomédecine |
hESC Derivation
Date of derivation | 2007-02-08 |
Embryo stage | Blastula with ICM and Trophoblast |
Supernumerary embryos from IVF treatment? |
Yes
|
PGD Embryo? |
Yes |
Expansion status |
2 |
ICM morphology |
B |
Trophectoderm morphology |
b |
ZP removal technique | Mechanical |
Cell isolation | Laser |
Cell seeding | Isolated ICM |
Culture Conditions
Feeder cells |
mouse embryonic fibroblast cell Cellfinder Ont Id: EFO_0004040 |
|||||||||
CO2 Concentration | 5 % | |||||||||
Medium |
Other medium:
Base medium: DMEM/F-12
Main protein source: Knock-out serum replacement Serum concentration: 20 % Supplements
|
Characterisation
Analysis of Undifferentiated Cells
Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
POU5F1 (OCT-4) |
Yes |
|
|
|
||
SSEA-4 |
Yes |
|
|
|||
TRA 1-60 |
Yes |
|
|
|||
CD9 |
Yes |
|
||||
DNMT3B |
Yes |
|
||||
GABRB3 |
Yes |
|
||||
GDF3 |
Yes |
|
||||
GRB7 |
Yes |
|
||||
LEFTB |
Yes |
|
||||
LIN28 |
Yes |
|
|
|||
NANOG |
Yes |
|
||||
ZFP42 (REX-1) |
Yes |
|
||||
SOX2 |
Yes |
|
|
|||
TDGF1 |
Yes |
|
||||
HESCA-1 |
Yes |
|
Differentiation Potency
Microbiology / Virus Screening |
|
HIV 1 | Negative |
HIV 2 | Negative |
Hepatitis B | Negative |
Hepatitis C | Negative |
Genotyping
Karyotyping (Cell Line) |
|
Has the cell line karyotype been analysed? |
Yes
46,XY,der(21)t(1;21)(p36;q22).ish der(21)(21qter-,1pter+).arr1p36.32p36.33(985,153-4,637,952)x3.arr21q22.3(43,659,526-49,928,776)x1
Passage number: 60
|
Other Genotyping (Cell Line) |
Login to share your feedback, experiences or results with the research community.